PreveCeutical Medical Inc

PreveCeutical Medical Inc. receives first cannabis shipment at Australia lab

PreveCeutical Medical Inc. (CSE:PREV, OTCMKTS:PRVCF) CEO Stephen Van Deventer tells Proactive Investors the health sciences company received its first shipment of dried cannabis flowers and oils from Aurora Cannabis to their lab in Australia.

Van Deventer says PreveCeutical are now profiling three different cannabis strains for the application of soluble gel (Sol-gel) drug-delivery technology to cannabinoids. Van Deventer says it will take about 18 months until a product is available.

Quick facts: PreveCeutical Medical Inc

Price: $0.04

Market: CSE
Market Cap: $13.88 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of PreveCeutical Medical Inc named herein, including the promotion by the Company of PreveCeutical Medical Inc in any Content on the Site, the...



PreveCeutical prepares for the final stage of their Sol-Gel program

PreveCeutical (CNSX:PREV) Chief Research Officer Dr Harry Parekh joined Steve Darling from Proactive Investors Vancouver to talk about the companies progress in the development of their sol-gel. Parekh telling proactive the next step they are undertaking with human tissue. He also talked...

on 27/4/19

2 min read